In the last trading session, 48.61 million shares of the Hims & Hers Health Inc (NYSE:HIMS) were traded, and its beta was 1.06. Most recently the company’s share price was $18.75, and it changed around -$0.69 or -3.55% from the last close, which brings the market valuation of the company to $4.06B. HIMS currently trades at a discount to its 52-week high of $25.74, offering almost -37.28% off that amount. The share price’s 52-week low was $5.65, which indicates that the current value has risen by an impressive 69.87% since then. We note from Hims & Hers Health Inc’s average daily trading volume that its 10-day average is 14.64 million shares, with the 3-month average coming to 8.75 million.

Hims & Hers Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.14. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 8 recommended HIMS as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Hims & Hers Health Inc is expected to report earnings per share of 0.04 for the current quarter.

Hims & Hers Health Inc (NYSE:HIMS) trade information

Instantly HIMS has showed a red trend with a performance of -3.55% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 19.99 on recent trading dayincreased the stock’s daily price by 6.2%. The company’s shares are currently up 110.67% year-to-date, but still down -2.90% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is 34.22% up in the 30-day period. We can see from the shorts that 26.54 million shares have been sold at a short interest cover period of 3.72 day(s).

The consensus price target as assigned by Wall Street analysts is $18, which translates to bulls needing to decrease their stock price by -4.17% from its current value. Analyst projections state that HIMS is forecast to be at a low of $5 and a high of $24.

Hims & Hers Health Inc (HIMS) estimates and forecasts

Hims & Hers Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 28.87 percent over the past six months and at a 300.00% annual growth rate that is well above the industry average of 23.90%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 200.00% in revenue this quarter, and will report an increase of 600.00% in the next quarter. The year-over-year growth rate is expected to be 58.30%, up from the previous year.

Consensus estimates provided by 13 financial analysts predict the company will bring in an average of 379.27M in revenue for the current quarter. 13 analysts expect Hims & Hers Health Inc to make 418.94M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 226.7M and 246.17M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 67.30%. Forecasts for the next quarter put sales growth at 70.20%.

HIMS Dividends

Hims & Hers Health Inc’s next quarterly earnings report is expected to be released in November.

Hims & Hers Health Inc (NYSE:HIMS)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 11.99% of Hims & Hers Health Inc shares, and 66.62% of them are in the hands of institutional investors. The stock currently has a share float of 75.69%. Hims & Hers Health Inc stock is held by 405.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 7.7166% of the shares, which is about 16.47 million shares worth $332.55 million.

BLACKROCK INC., with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.